Advertisement

Topics

Drug Facts | Lamisil

04:28 EDT 27th August 2014 | BioPortfolio

Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Terbinafine hydrochloride

Antifungal

For external use only

do not get into eyes. If eye contact occurs, rinse thoroughly with water.

if too much irritation occurs or gets worse

If swallowed, get medical help or contact a poison control center right away.

benzyl alcohol, cetyl alcohol, cetyl palmitate, isopropyl myristate, polysorbate 60, purified water, sodium hydroxide, sorbitan monostearate, stearyl alcohol.

call 1-800-452-0051

Novartis Consumer Health, Inc.

Parsippany, NJ 07054-0622 ©2008

IMAGE b666efb8-bcff-43da-8c45-1e223f8a12f0-03.jpg

Manufacturer

Novartis Consumer Health, Inc.

Active Ingredients

Source

Drugs and Medications [3 Associated Drugs and Medications listed on BioPortfolio]

Lamisil [Novartis Pharmaceuticals Corporation]

These highlights do not include all the information needed to use   Lamisil Tablets   safely and effectively.   See full prescribing information for   L amisil Tablets .

Lamisil [Novartis Consumer Health, Inc.]

Drug Facts

Lamisil [Novartis Pharmaceuticals Corporation]

These highlights do not include all the information needed to use Lamisil Oral Granules safely and effectively. See full prescribing information for Lamisil Oral Granules. Lamisil

Clinical Trials [6 Associated Clinical Trials listed on BioPortfolio]

Fed Study of Terbinafine Hydrochloride Tablets 250 mg and Lamisil® 250 mg

The objective of this study was to investigate the bioequivalence of Mylan's terbinafine hydrochloride tablets to Novartis' Lamisil® tablets following a single, oral 250 mg (1 x 250 mg) d...

Fasting Study of Terbinafine Hydrochloride Tablets 250 mg and Lamisil® Tablets 250 mg

The objective of this study was to investigate the bioequivalence of Mylan's terbinafine hydrochloride 250 mg tablets to Novartis' Lamisil® 250 mg tablets following a single, oral 250 mg ...

Terbinafine HCl 250 mg Tablet Formulations Under Non-Fasting Conditions

The Purpose of this study os to evaluate the relative bioavailability of the test formulation of terbinafine tablets with an already marketed reference formulation Lamisil® (Novartis Phar...

Bioequivalency Study of Terbinafine Tablets Under Fed Conditions

The objective of this study was the bioequivalence of a Roxane Laboratories' terbinafine tablets, 250 mg, to Lamisil® Tablets, 250 mg (Novartis Pharmaceutical Corporation.) under fed cond...

Bioequivalency Study of Terbinafine Tablets Under Fasting Conditions

The objective of this study was the bioequivalence of a Roxane Laboratories' terbinafine tablets, 250 mg, to Lamisil® Tablets, 250 mg (Novartis Pharmaceutical Corporation.) under fasting ...

PubMed Articles [0 Results]

None

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Drugs and Medication Quicklinks


Searches Linking to this Drug Record